Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems.
暂无分享,去创建一个
R. Szabó | G. Mező | Gitta Schlosser | J. Tóvári | K. N. Enyedi | Bence Kapuvári | Beáta Biri‐Kovács | Ivan Ranđelović | Á. Orosz | K. Kiss
[1] L. Buday,et al. Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification , 2018, Pharmaceutics.
[2] L. Buday,et al. Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery , 2018, Beilstein journal of organic chemistry.
[3] G. Multhoff,et al. Membrane heat shock protein 70: a theranostic target for cancer therapy , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.
[4] A. Iyer,et al. Advances in antibody-drug conjugates: A new era of targeted cancer therapy. , 2017, Drug discovery today.
[5] Bin Zhang,et al. A colon targeted drug delivery system based on alginate modificated graphene oxide for colorectal liver metastasis. , 2017, Materials science & engineering. C, Materials for biological applications.
[6] S. Kawakami,et al. Peptide-Based Cancer-Targeted DDS and Molecular Imaging. , 2017, Chemical & pharmaceutical bulletin.
[7] G. Szakács,et al. NGR-peptide−drug conjugates with dual targeting properties , 2017, PloS one.
[8] G. Mező,et al. Oligo- and polypeptide conjugates of cationic porphyrins: binding, cellular uptake, and cellular localization , 2017, Amino Acids.
[9] G. Gellerman,et al. Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells , 2016, Biomedicines.
[10] G. Mező,et al. Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice , 2016, Investigational New Drugs.
[11] V. V. Padma,et al. An overview of targeted cancer therapy , 2015, BioMedicine.
[12] Hubiao Chen,et al. Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy , 2015, International journal of molecular sciences.
[13] A. Chakrabarti,et al. Hemoglobin interacting proteins and implications of spectrin hemoglobin interaction. , 2015, Journal of proteomics.
[14] D. Andreu,et al. Modification of daunorubicin‐GnRH‐III bioconjugates with oligoethylene glycol derivatives to improve solubility and bioavailability for targeted cancer chemotherapy , 2015, Biopolymers.
[15] T. Baudino,et al. Targeted Cancer Therapy: The Next Generation of Cancer Treatment. , 2015, Current drug discovery technologies.
[16] J. Shaw,et al. Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. , 2013, Critical reviews in oncology/hematology.
[17] É. Kiss,et al. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates. , 2012, European journal of medicinal chemistry.
[18] Rahul Kumar,et al. TumorHoPe: A Database of Tumor Homing Peptides , 2012, PloS one.
[19] S. Bősze,et al. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[20] G. Mező,et al. In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites , 2011, Amino Acids.
[21] G. Mező,et al. Receptor-mediated tumor targeting based on peptide hormones , 2010, Expert opinion on drug delivery.
[22] A. Schally,et al. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin , 2008, Anti-cancer drugs.
[23] Zhiyuan Hu,et al. Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library , 2007, Journal of biomolecular screening.
[24] C. Peterson,et al. Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N-terminal beta-globin chain peptides. , 1997, Alcoholism, clinical and experimental research.
[25] J. Sambrook,et al. Common and divergent peptide binding specificities of hsp70 molecular chaperones. , 1994, The Journal of biological chemistry.
[26] P. Laakkonen,et al. Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display. , 2015, Methods in molecular biology.